Sign up to see all 5.
Sign up to see all 5.
No insider has filed a notice of proposed sale (Form 144) for Nephros Inc in the last 12 months.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
WC
Wexford Capital LP
13D · 2.1%
|
3.6M | 33.15% | Unchanged | 2021 | 1.6% | |
|
Shares held by quarter
Peak holding3.6M (Q3'25)
Change over 8 quarters0
Share of the company33.150%
Disclosed stake13D · 2.1%
|
||||||
|
TC
Topline Capital Management, LLC
|
535.7K | 4.93% | −46.3K (−8.0%) | 2024 | 0.5% | |
|
Shares held by quarter
Peak holding614.3K (Q4'25)
Change over 8 quarters+535.7K
Share of the company4.930%
|
||||||
24 more super investors behind a free account
See every manager holding Nephros Inc, how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
VT
Vanguard Index Funds
|
$467K | 130.9K | 1.21% | 0.00% | June 30, 2026 |
|
VE
Vanguard Index Funds
|
$242K | 67.7K | 0.62% | 0.00% | June 30, 2026 |
14 more funds behind a free account
See every fund holding Nephros Inc and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
WG
Wexford GP LLC
5%+ holder
13D · 2.1%
|
223.5K | 2.06% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
|
CE
Charles E. Davidson
5%+ holder
13D · 2.1%
|
223.5K | 2.06% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
Loading...